As CTO of Bionic Vision Technologies (BVT), Brian oversees the product development & clinical trials of BVT’s Bionic Eye, a device that provides a sense of vision to people who are blind. Brian will explain the need for bionic eyes and how they work. Brian will then cover Bionic Vision Technologies’ commercialisation journey so far and latest clinical results.
Brian has twenty years of experience in product development, including 18 years in class III medical devices. Prior to joining BVT, Brian has held various senior engineering roles at Cochlear Ltd and has taken many products from idea to market, ranging in complexity from a single industrial designer to leading a program of over 100 engineers across the world with a complex mix of internal manufacturing sites and global supply chain.
Bionic Vision Technologies has developed the BVT Bionic Eye System, the world’s first suprachoroidal visual implant, to restore functional vision to the blind suffering from inherited retinal diseases.
The Company has recently completed initial human testing in seven patients demonstrating safety and efficacy with positive outcomes in patient mobility and device stability/durability.
We intend to initiate a worldwide clinical trial in key markets, including Australia, USA and Europe, with commercialization anticipated soon after.